InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Lake Ryan David, Chief Financial Officer. Director active across 2 companies, notably Recro Pharma, Inc.. In total, 21 filings have been logged. Total volume traded: €3k. The latest transaction was disclosed on 31 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations21 total
€8251,197 shares@ €0.68940.0000% mcap3.8% of flow
Common Stock
SEC:0001062993-22-014139:0·
€1,5281,198 shares@ €1.27570.0000% mcap7.0% of flow
Common Stock
SEC:0001062993-22-011487:0·
€19,35513,306 shares@ €1.45460.0000% mcap89.2% of flow
Common Stock
SEC:0001062993-22-009512:0·
€1,3911,021 shares@ €1.36282.1% of flow
Common Stock
SEC:0001062993-22-002640·
€1,3911,021 shares@ €1.36281.0% of flow
Common Stock
SEC:0001062993-22-002640:0·
€1,9591,419 shares@ €1.38092.9% of flow
Common Stock
SEC:0000899243-22-004168·
€1,9591,419 shares@ €1.38091.5% of flow
Common Stock
SEC:0000899243-22-004168:0·
39,604 shares
Common Stock
SEC:0000899243-22-003084·
39,604 shares
Common Stock
SEC:0000899243-22-003084:0·
€1,5821,094 shares@ €1.4462.4% of flow
Common Stock
SEC:0000899243-22-002422·
€1,5821,094 shares@ €1.4461.2% of flow
Common Stock
SEC:0000899243-22-002422:0·
€43,38028,730 shares@ €1.509965.1% of flow
Common Stock
SEC:0000899243-22-000720·
€43,38028,730 shares@ €1.509932.5% of flow
Common Stock
SEC:0000899243-22-000720:0·
€8,1355,690 shares@ €1.429712.2% of flow
Common Stock
SEC:0000899243-21-048869·
€8,1355,690 shares@ €1.42976.1% of flow
Common Stock
SEC:0000899243-21-048869:0·
€1,6731,162 shares@ €1.44012.5% of flow
Common Stock
SEC:0000899243-21-044710·
Ideal exit: 9 Aug 2022 (T+270)
€1,6731,162 shares@ €1.44011.3% of flow
Common Stock
SEC:0000899243-21-044710:0·
Ideal exit: 9 Aug 2022 (T+270)
€8,5565,172 shares@ €1.654312.8% of flow
Common Stock
SEC:0000899243-21-028185·
€8,5565,172 shares@ €1.65436.4% of flow
Common Stock
SEC:0000899243-21-028185:0·
2,500 shares
Common Stock
SEC:0001192482-21-000496·
2,500 shares
Common Stock
SEC:0001192482-21-000496:0·
21 of 21 declarations
About Lake Ryan David
Ryan David Lake is an executive at Recro Pharma, Inc.
